Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,235,108,212
+$90,061,771 QoQ
Shares Held
2,486,478
-3.0% QoQ
Ownership
0.981%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#21
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. VRTX ranks #1 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,235,108,212 | 2,486,478 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,145,046,441 | 2,564,264 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,169,422,622 | 2,579,457 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,029,185,660 | 2,627,887 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,183,600,257 | 2,658,581 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,269,933,624 | 2,619,392 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,095,766,430 | 2,721,049 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,100,375,558 | 2,365,992 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,187,691,480 | 2,533,904 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,077,812,449 | 2,578,437 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,090,708,111 | 2,680,597 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $978,388,397 | 2,813,563 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $943,831,064 | 2,682,024 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $874,853,293 | 2,776,695 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $823,473,205 | 2,851,559 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $836,190,938 | 2,887,998 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $827,598,629 | 2,936,934 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $754,191,031 | 2,889,953 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $638,674,097 | 2,908,352 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $543,170,538 | 2,994,490 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $599,408,888 | 2,972,816 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $639,996,141 | 2,978,250 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $714,338,593 | 3,022,504 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $843,001,906 | 3,097,905 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $864,516,469 | 2,977,908 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $680,527,243 | 2,859,959 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||